Announcements Trials

Browse Landscape

Sponsor

Conditions

Breast Neoplasms 6 Malignant Solid Neoplasm 1 Inflammatory Breast Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms, Male 1 Bladder Urothelial Carcinoma 1 Advanced Breast Carcinoma 1 Adenocarcinoma Of Esophagus 1

Interventions

Bevacizumab 112 Fluorouracil 98 Oxaliplatin 96 Leucovorin 96 Irinotecan 86 Capecitabine 73 Cetuximab 64 Panitumumab 42 pembrolizumab 38 regorafenib 28 Nivolumab 23 IFL protocol 22 Folfox protocol 21 trifluridine tipiracil drug combination 14 Radiotherapy 13 durvalumab 11 Gemcitabine 10 Celecoxib 10 tremelimumab 7 binimetinib 7 aflibercept 7 Drug Therapy 7 Disulfides 7 Cyclophosphamide 7 Trifluridine 6 Trastuzumab 6 Sunitinib 6 Paclitaxel 6 Immunoglobulin G 6 Colonoscopy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Colorectal Neoplasms × trastuzumab biosimilar HLX02 × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡